Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

[Study of associations of polymorphism of matrix metalloproteinases genes with the development of arterial hypertension in men].

Moskalenko MI, Milanova SN, Ponomarenko IV, Polonikov AV, Churnosov MI.

Kardiologiia. 2019 Aug 23;59(7S):31-39. doi: 10.18087/cardio.2598. Russian.

PMID:
31441739
2.

[The role of stress factors and genetic predisposition in the development of stroke in patients with essential hypertension].

Moskalenko MI, Ponomarenko IV, Polonikov AV, Zhernakova NI, Efremova OA, Churnosov MI.

Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(3. Vyp. 2):11-17. doi: 10.17116/jnevro201911903211. Russian.

PMID:
31184620
3.

Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models.

Xiong H, Mittman S, Rodriguez R, Pacheco-Sanchez P, Moskalenko M, Yang Y, Elstrott J, Ritter AT, Müller S, Nickles D, Arenzana TL, Capietto AH, Delamarre L, Modrusan Z, Rutz S, Mellman I, Cubas R.

Cancer Immunol Res. 2019 Jun;7(6):963-976. doi: 10.1158/2326-6066.CIR-18-0750. Epub 2019 May 7.

PMID:
31064777
4.

Anti-PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment.

Xiong H, Mittman S, Rodriguez R, Moskalenko M, Pacheco-Sanchez P, Yang Y, Nickles D, Cubas R.

Cancer Res. 2019 Apr 1;79(7):1493-1506. doi: 10.1158/0008-5472.CAN-18-3208. Epub 2019 Jan 24.

PMID:
30679180
5.

Chemotherapy Combines Effectively with Anti-PD-L1 Treatment and Can Augment Antitumor Responses.

Cubas R, Moskalenko M, Cheung J, Yang M, McNamara E, Xiong H, Hoves S, Ries CH, Kim J, Gould S.

J Immunol. 2018 Oct 15;201(8):2273-2286. doi: 10.4049/jimmunol.1800275. Epub 2018 Sep 12.

PMID:
30209192
6.

Incidence of Surgical Site Infections after Thyroid and Parathyroid Surgery: No Role for Antimicrobial Prophylaxis.

Moskalenko M, Asai M, Beem K, Pezzi TA, Brophy CL, Noonan K, Pezzi CM.

Am Surg. 2018 Jun 1;84(6):897-901.

PMID:
29981621
7.

Artist's Statement: Abstract Art as Reflective Practice.

Moskalenko M, Mitchell M, Rosenzweig S.

Acad Med. 2017 Feb;92(2):146. doi: 10.1097/ACM.0000000000001524. No abstract available.

PMID:
28118251
8.

Nuclear receptor REV-ERBα mediates circadian sensitivity to mortality in murine vesicular stomatitis virus-induced encephalitis.

Gagnidze K, Hajdarovic KH, Moskalenko M, Karatsoreos IN, McEwen BS, Bulloch K.

Proc Natl Acad Sci U S A. 2016 May 17;113(20):5730-5. doi: 10.1073/pnas.1520489113. Epub 2016 May 3.

9.

MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade.

Ebert PJR, Cheung J, Yang Y, McNamara E, Hong R, Moskalenko M, Gould SE, Maecker H, Irving BA, Kim JM, Belvin M, Mellman I.

Immunity. 2016 Mar 15;44(3):609-621. doi: 10.1016/j.immuni.2016.01.024. Epub 2016 Mar 2.

10.

Chiral Cobalt(III) Complexes as Bifunctional Brønsted Acid-Lewis Base Catalysts for the Preparation of Cyclic Organic Carbonates.

Rulev YA, Larionov VA, Lokutova AV, Moskalenko MA, Lependina OL, Maleev VI, North M, Belokon YN.

ChemSusChem. 2016 Jan;9(2):216-22. doi: 10.1002/cssc.201501365. Epub 2015 Dec 14.

PMID:
26663897
11.

Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanomas.

de Moll EH, Fu Y, Qian Y, Perkins SH, Wieder S, Gnjatic S, Remark R, Bernardo SG, Moskalenko M, Yao J, Ferringer T, Chang R, Chipuk J, Horst BA, Birge MB, Phelps RG, Saenger YM.

Cancer Immunol Immunother. 2015 Sep;64(9):1193-203. doi: 10.1007/s00262-015-1726-0. Epub 2015 Jun 16.

12.

Requirement for innate immunity and CD90⁺ NK1.1⁻ lymphocytes to treat established melanoma with chemo-immunotherapy.

Moskalenko M, Pan M, Fu Y, de Moll EH, Hashimoto D, Mortha A, Leboeuf M, Jayaraman P, Bernardo S, Sikora AG, Wolchok J, Bhardwaj N, Merad M, Saenger Y.

Cancer Immunol Res. 2015 Mar;3(3):296-304. doi: 10.1158/2326-6066.CIR-14-0120. Epub 2015 Jan 19.

13.

Instructional video for teaching venepuncture.

Pan M, Harcharik S, Moskalenko M, Luber A, Bernardo S, Levitt J.

Clin Teach. 2014 Oct;11(6):436-41. doi: 10.1111/tct.12198. Erratum in: Clin Teach. 2014 Dec;11(7):575.

PMID:
25212929
14.

Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.

Harcharik S, Bernardo S, Moskalenko M, Pan M, Sivendran M, Bell H, Hall LD, Castillo-Martín M, Fox K, Cordon-Cardo C, Chang R, Sivendran S, Phelps RG, Saenger Y.

J Am Acad Dermatol. 2014 Jun;70(6):1036-44. doi: 10.1016/j.jaad.2014.01.914. Epub 2014 Mar 31.

PMID:
24698703
15.

Dissection of immune gene networks in primary melanoma tumors critical for antitumor surveillance of patients with stage II-III resectable disease.

Sivendran S, Chang R, Pham L, Phelps RG, Harcharik ST, Hall LD, Bernardo SG, Moskalenko MM, Sivendran M, Fu Y, de Moll EH, Pan M, Moon JY, Arora S, Cohain A, DiFeo A, Ferringer TC, Tismenetsky M, Tsui CL, Friedlander PA, Parides MK, Banchereau J, Chaussabel D, Lebwohl MG, Wolchok JD, Bhardwaj N, Burakoff SJ, Oh WK, Palucka K, Merad M, Schadt EE, Saenger YM.

J Invest Dermatol. 2014 Aug;134(8):2202-2211. doi: 10.1038/jid.2014.85. Epub 2014 Feb 12.

16.

Modulation sensitivity in the perceptual organization of speech.

Remez RE, Thomas EF, Dubowski KR, Koinis SM, Porter NA, Paddu NU, Moskalenko M, Grossman YS.

Atten Percept Psychophys. 2013 Oct;75(7):1353-8. doi: 10.3758/s13414-013-0542-x.

17.

Caspase-2 is essential for c-Jun transcriptional activation and Bim induction in neuron death.

Jean YY, Ribe EM, Pero ME, Moskalenko M, Iqbal Z, Marks LJ, Greene LA, Troy CM.

Biochem J. 2013 Oct 1;455(1):15-25. doi: 10.1042/BJ20130556.

18.

Depletion of regulatory T cells by targeting folate receptor 4 enhances the potency of a GM-CSF-secreting tumor cell immunotherapy.

Liang SC, Moskalenko M, Van Roey M, Jooss K.

Clin Immunol. 2013 Aug;148(2):287-98. doi: 10.1016/j.clim.2013.05.011. Epub 2013 May 25.

PMID:
23811319
19.

Elevated rates of transaminitis during ipilimumab therapy for metastatic melanoma.

Bernardo SG, Moskalenko M, Pan M, Shah S, Sidhu HK, Sicular S, Harcharik S, Chang R, Friedlander P, Saenger YM.

Melanoma Res. 2013 Feb;23(1):47-54. doi: 10.1097/CMR.0b013e32835c7e68.

PMID:
23262440
20.

Estimating speech spectra for copy synthesis by linear prediction and by hand.

Remez RE, Dubowski KR, Davids ML, Thomas EF, Paddu NU, Grossman YS, Moskalenko M.

J Acoust Soc Am. 2011 Oct;130(4):2173-8. doi: 10.1121/1.3631667.

21.

Using the same organocatalyst for asymmetric synthesis of both enantiomers of glutamic acid-derived Ni(II) complexes via 1,4-additions of achiral glycine and dehydroalanine Schiff base Ni(II) complexes.

Belokon YN, Gugkaeva ZT, Hakobyan KV, Maleev VI, Moskalenko MA, Khrustalev VN, Saghyan AS, Tsaloev AT, Babievsky KK.

Amino Acids. 2012 Jul;43(1):299-308. doi: 10.1007/s00726-011-1076-y. Epub 2011 Sep 21.

PMID:
21935708
22.

[Age-specific characteristics of acute myeloid leukemia karyotype].

Gritsaev SV, Martynkevich IS, Martynenko LS, Ivanova MP, Aksenova VIu, Moskalenko MV, Zapreeva IM, Abdulkadyrov KM.

Ter Arkh. 2011;83(1):51-5. Russian.

PMID:
21446203
23.

Auditory-phonetic projection and lexical structure in the recognition of sine-wave words.

Remez RE, Dubowski KR, Broder RS, Davids ML, Grossman YS, Moskalenko M, Pardo JS, Hasbun SM.

J Exp Psychol Hum Percept Perform. 2011 Jun;37(3):968-77. doi: 10.1037/a0020734.

PMID:
21443384
24.

Glucocorticoid receptor gene polymorphism and juvenile idiopathic arthritis.

Kostik MM, Klyushina AA, Moskalenko MV, Scheplyagina LA, Larionova VI.

Pediatr Rheumatol Online J. 2011 Jan 13;9(1):2. doi: 10.1186/1546-0096-9-2.

25.

[Analysis of polymorphism of bone metabolism genes and evaluation of the risk of osteopenia in cosmonauts].

Oganov VS, Baranov VS, Kabitskaia OE, Novikov VE, Bakulin AV, Moskalenko MV, Aseev MV, Voĭtulevich LV.

Aviakosm Ekolog Med. 2010 May-Jun;44(3):18-23. Russian.

PMID:
21033393
26.

Asymmetric synthesis of enantiomerically and diastereoisomerically enriched 4-[F or Br]-substituted glutamic acids.

Belokon YN, Maleev VI, Savel'eva TF, Moskalenko MA, Pripadchev DA, Khrustalev VN, Saghiyan AS.

Amino Acids. 2010 Nov;39(5):1171-6. doi: 10.1007/s00726-010-0551-1. Epub 2010 Mar 20.

PMID:
20306095
27.

[FLT3 and NPM1 gene mutations in patients with acute myeloid leukemias and the impact of FLT3-ITD mutations on the survival of patients with a normal karyotype].

Martynkevich IS, Gritsaev SV, Moskalenko MV, Ivanova MP, Aksenova VIu, Tiranova SA, Abdulkadyrov KM.

Ter Arkh. 2010;82(12):33-9. Russian.

PMID:
21516736
28.

[Investigation of FLT3-ITD and NPM1 mutations in patients with myelodysplastic syndrome and mixed myeloid diseases].

Gritsaev SV, Martynkevich IS, Ivanova MP, Moskalenko MV, Aksenova VIu, Tiranova SA, Abdulkadyrov KM.

Vopr Onkol. 2010;56(6):671-6. Russian.

PMID:
21395122
29.

Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.

Li B, Simmons A, Du T, Lin C, Moskalenko M, Gonzalez-Edick M, VanRoey M, Jooss K.

Clin Immunol. 2009 Nov;133(2):184-97. doi: 10.1016/j.clim.2009.07.008. Epub 2009 Aug 7.

PMID:
19664962
30.

AUDITORY-PHONETIC PROJECTION AND LEXICAL STRUCTURE IN THE RECOGNITION OF SINE-WAVE WORDS.

Remez RE, Dubowski KR, Broder RS, Davids ML, Grossman YS, Moskalenko M, Pardo JS, Hasbun SM.

J Exp Psychol Hum Percept Perform. 2009 Apr 1;125(4):2656.

31.

[Correlation between the bone mass of athletes and biochemical and genetic markers of bone tissue remodeling].

Oganov VS, Vinogradova OL, Dudov NS, Baranov VS, Minenkov AS, Bakulin AV, Novikov VE, Kabitskaia OE, Moskalenko MV, Glotov AS, Glotov OS, Popov DV.

Fiziol Cheloveka. 2008 Mar-Apr;34(2):56-65. Russian. No abstract available.

PMID:
18472573
32.

Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity.

Simmons AD, Moskalenko M, Creson J, Fang J, Yi S, VanRoey MJ, Allison JP, Jooss K.

Cancer Immunol Immunother. 2008 Aug;57(8):1263-70. doi: 10.1007/s00262-008-0451-3. Epub 2008 Jan 31.

PMID:
18236040
33.

Genetic determinants of the efficiency of climatotherapy in patients with chronic heart failure.

Kovlen DV, Tishakov AY, Glotov OS, Moskalenko MV, Demin GS, Bitsadze AN, Chernyshev AV, Bratova NI, Ivashchenko TE, Obrezan AG, Ponomarenko GN.

Bull Exp Biol Med. 2007 Jan;143(1):26-31.

PMID:
18019005
34.

GM-CSF-secreting cancer immunotherapies: preclinical analysis of the mechanism of action.

Simmons AD, Li B, Gonzalez-Edick M, Lin C, Moskalenko M, Du T, Creson J, VanRoey MJ, Jooss K.

Cancer Immunol Immunother. 2007 Oct;56(10):1653-65. Epub 2007 Apr 5.

PMID:
17410360
35.

[A pathogenetic model of cerebral palsy in children born to mothers with antiphospholipid syndrome].

Evtushenko SK, Moskalenko MA, Evtushenko OS, Evtushenko IS.

Zh Nevrol Psikhiatr Im S S Korsakova. 2006;106(7):46-51. Russian.

PMID:
16921719
36.

[The role of gene nets in realization of therapeutic effects of climate therapy in patients with chronic cardiac failure].

Kovlen DV, Ponomarenko GN, Tishakov AIu, Glotov OS, Moskalenko MV, Demin GS, Bratova NI, Ivashchenko TE, Obrezan AG.

Vopr Kurortol Fizioter Lech Fiz Kult. 2006 May-Jun;(3):5-9. Review. Russian. No abstract available.

PMID:
16862883
37.

In situ formation of a heterobimetallic chiral [(salen)Ti(IV)]/[(salen)V(V)] catalyst for the asymmetric addition of TMSCN to benzaldehyde.

Belokon YN, North M, Maleev VI, Voskoboev NV, Moskalenko MA, Peregudov AS, Dmitriev AV, Ikonnikov NS, Kagan HB.

Angew Chem Int Ed Engl. 2004 Aug 6;43(31):4085-9. No abstract available.

PMID:
15300702
38.

[Strokes and their causes in children].

Evtushenko SK, Evtushenko OS, Perepechaenko IuM, Moskalenko MA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2003;(Suppl 8):30-5. Russian.

PMID:
12830515
39.

[Analysis of association of Col1a1 gene alleles with the development of osteoporosis].

Moskalenko MV, Aseev MV, Zazerskaia IE, Kotova SM, Ivashchenko TE, Baranov VS.

Genetika. 2002 Dec;38(12):1699-703. Russian.

PMID:
12575457
40.

Catalytic asymmetric synthesis of O-acetyl cyanohydrins from KCN, Ac2O and aldehydes.

Belokon YN, Gutnov AV, Moskalenko MA, Yashkina LV, Lesovoy DE, Ikonnikov NS, Larichev VS, North M.

Chem Commun (Camb). 2002 Feb 7;(3):244-5.

PMID:
12120386
41.

Production of human clotting Factor IX without toxicity in mice after vascular delivery of a lentiviral vector.

Tsui LV, Kelly M, Zayek N, Rojas V, Ho K, Ge Y, Moskalenko M, Mondesire J, Davis J, Roey MV, Dull T, McArthur JG.

Nat Biotechnol. 2002 Jan;20(1):53-7.

PMID:
11753362
42.

Anti-Tumor CC49-zeta CD4 T cells possess both cytolytic and helper functions.

Patel SD, Ge Y, Moskalenko M, McArthur JG.

J Immunother. 2000 Nov-Dec;23(6):661-8.

PMID:
11186154
43.

T-cell killing of heterogenous tumor or viral targets with bispecific chimeric immune receptors.

Patel SD, Moskalenko M, Tian T, Smith D, McGuinness R, Chen L, Winslow GA, Kashmiri S, Schlom J, Stanners CP, Finer MH, McArthur JG.

Cancer Gene Ther. 2000 Aug;7(8):1127-34.

44.

The p53-independent tumoricidal activity of an adenoviral vector encoding a p27-p16 fusion tumor suppressor gene.

Patel SD, Tran AC, Ge Y, Moskalenko M, Tsui L, Banik G, Tom W, Scott M, Chen L, Van Roey M, Rivkin M, Mendez M, Gyuris J, McArthur JG.

Mol Ther. 2000 Aug;2(2):161-9.

45.

Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: implications for gene therapy and virus structure.

Moskalenko M, Chen L, van Roey M, Donahue BA, Snyder RO, McArthur JG, Patel SD.

J Virol. 2000 Feb;74(4):1761-6.

46.

Impact of chimeric immune receptor extracellular protein domains on T cell function.

Patel SD, Moskalenko M, Smith D, Maske B, Finer MH, McArthur JG.

Gene Ther. 1999 Mar;6(3):412-9.

47.

T cell tolerance is influenced by concomitant T cell recognition of cross-reactive self-peptides.

Tam RC, Fedoseyeva EV, Moskalenko M, Garovoy MR, Benichou G.

J Immunol. 1996 May 15;156(10):3765-71.

PMID:
8621912
48.

[The immunomodulating action of interferon preparations. 3. Changes in the phagocytic activity of human blood neutrophilic granulocytes under the influence of interferon preparations].

Avdeeva ZhI, Mazina NM, Vakhromeeva NS, Krylov OP, Moskalenko MB, Medunitsyn NV.

Vestn Dermatol Venerol. 1990;(8):23-8. Russian.

PMID:
1701593
49.

[Nature of penicillin receptor sites and some aspects of metabolism of penicillin resistant forms of bacteria].

Torbochkina LI, Moskalenko MG.

Antibiotiki. 1970 Oct;15(10):872-6. Russian. No abstract available.

PMID:
4922624
50.

[Development and function of sex organs in adolescent girls with central spastic paralysis].

Baksheev MS, Moskalenko MA.

Pediatr Akus Ginekol. 1969;31(6):33-6. Ukrainian. No abstract available.

PMID:
5408746

Supplemental Content

Loading ...
Support Center